摘要
目的探讨腹腔镜下卵巢巧克力囊肿剥除术后给予米非司酮或孕三烯酮口服治疗预防囊肿复发的疗效。方法回顾分析卵巢巧克力囊肿患者56例,行腹腔镜手术后给予米非司酮(A组33例)及孕三烯酮(B组23例)预防复发的疗效观察。结果卵巢子宫内膜异位囊肿腹腔镜剥除术后给予米非司酮组较孕三烯酮组临床症状显效率及有效率高,差异有统计学意义(P<0.05);在预防子宫内膜异位囊肿复发米非司酮组与孕三烯酮组之间无统计学意义(P>0.05)。结论卵巢子宫内膜异位囊肿腹腔镜剥除术后给予米非司酮在改善患者痛经等临床症状方面优于孕三烯酮,两组预防巧囊复发无明显差异。
Objective To investigate the curative effect comparison of medicine treatment between Mifepristone and Gestrinone after laparoscopy in treating ovarian cysts in endometriosis. Methods 56 patients with ovarian endometrial implantation were randomly divided into 2 groups : the patients in group A was administrated Mifepristone after the laparoscopy, and the patients in group B was administrated Gestrinone after the laparoscopy. The results were compared between 2 groups. Results The effectiveness in group A was significantly higher than that in group B (P 〈 0.05 ). There was no difference in recurrence rate between group A and group B ( P 〉 0.05 ). Conclusion Laparoscopy is suitable for the treatment of ovarian cysts in endometriosis. It is effective by using Mifepristone after the Laparoscopy in treating ovarian cysts in endometriosis.
出处
《宁夏医学杂志》
CAS
2011年第7期622-623,共2页
Ningxia Medical Journal